Inhibitors of Akt activity
Details for Australian Patent Application No. 2007328286 (hide)
International Classifications
Event Publications
18 June 2009 PCT application entered the National Phase
PCT publication WO2008/070016 Priority application(s): WO2008/070016
6 August 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 08 Jul 2009
21 January 2010 Alteration of Name
The name of the applicant has been altered to Banyu Pharmaceutical Co., Ltd.; Merck Sharp & Dohme Corp.
20 January 2011 Application Accepted
Published as AU-B-2007328286
24 March 2011 Assignment before Grant
Merck Sharp & Dohme Corp.; MSD K.K. The application has been assigned to Merck Sharp & Dohme Corp.; MSD K.K.
19 May 2011 Standard Patent Sealed
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.; MSD K.K.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007328296-Construction panels and construction systems, and methods
2007328281-Combination of an HDAC inhibitor and an antimetabolite
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser